Neoadjuvant sintilimab and chemotherapy for resectable esophageal squamous cell carcinoma: a phase II clinical trial

Authors

Chengrui Qiao
Jincheng Guo (ORCID: https://orcid.org/0000-0002-5616-6910)
Hui Pang (ORCID: https://orcid.org/0000-0002-2806-2276)
Boyi Zhang (ORCID: https://orcid.org/0000-0001-8418-2275)
Jiabin Lu
Shiqing Yang
Dongxia Tang

Institutions

Henan Polytechnic University (CN)

Publication Details

Journal: Frontiers in Immunology
Published: 2025-04-07
DOI: https://doi.org/10.3389/fimmu.2025.1486275
Citations: 1
Primary Topic: Esophageal Cancer Research and Treatment
Type: article
Field-Weighted Citation Impact: 2.01

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Neoadjuvant sintilimab and chemotherapy for resectable esophageal squamous cell carcinoma: a phase II clinical trial

Chengrui Qiao, Jincheng Guo, Hui Pang, Boyi Zhang et al.

Apr 7, 2025

1 citations

Frontiers in Immunology

Esophageal Cancer Research and Treatment

2.01

article

Neoadjuvant sintilimab and chemotherapy for resectable esophageal squamous cell carcinoma: a phase II clinical trial

Chengrui Qiao, Jincheng Guo, Hui Pang, Boyi Zhang, Jiabin Lu, Shiqing Yang, Dongxia Tang

April 7, 2025article en

1 citations

Abstract

No abstract available for this paper.

Frontiers in ImmunologyVol. 16

Henan Polytechnic University (CN)

Openalex Percentile: Top 17%

Esophageal Cancer Research and Treatment

2.01

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Neoadjuvant sintilimab and chemotherapy for resectable esophageal squamous cell carcinoma: a phase II clinical trial — Chengrui Qiao, Jincheng Guo, et al. · Frontiers in Immunology (2025) | TGRS Research Map | TGRS